Current report
according to ASF Regulation no. 5/2018
|
Report date:
|
24.02.2021
|
|
Name of issuer:
|
Farmaceutica REMEDIA
|
|
Registered office:
|
Deva,B-dul Nicolae Balcescu nr.2.
|
|
Tel/ fax no:
|
0254 22 32 60 / 0254 22 61 97
|
|
ORC no:
|
2115198
|
|
Trade Registry no:
|
J20 / 700 / 1991
|
|
Subscribed and paid-in capital:
|
RON 10,608,980
|
|
Regulated market:
|
Bucharest Stock Exchange, Standard Cathegory
|
Important events to report:
Dear investors,
We hereby present the DECISION NO. 76 of the Extraordinary General Meeting of Shareholders of the trading company Farmaceutica REMEDIA S.A. as of February 24th, 2021
DECISION NO. 76 of February 24th 2021
of the Extraordinary General Meeting of Shareholders
Farmaceutica REMEDIA S.A.
J20/700/1991, CUI RO 2115198
Adopted today, 24.02.2021 at the secondary headquarters of the company from BUCHAREST, B-dul Metalurgiei no. 78, sector 4.
Following the debate of the items on the agenda,
Considering the provisions of art. 207 para (1) lit. c) of Law no. 31 of 1990 of commercial companies,
the Extraordinary General Meeting of Shareholders decides, with the vote of the shareholders present and represented holding a number of 80.679.151 voting shares, representing 76,0480% of the total number of voting shares in the share capital of Farmaceutica REMEDIA SA (total voting shares 106,089,800 representing 100% of the share capital of Farmaceutica REMEDIA S.A.), the following:
Art. 1. Following the debate of the first point on the agenda, the Extraordinary General Meeting of the Shareholders decides, unanimously, by the votes of the shareholders present and represented:
Approval of the reduction of the share capital with the amount of 1.060.898 lei, from 10.608.980 lei to 9.548.082 lei, as a result of the cancellation of a number of 10.608.980 registered shares, dematerialized, in nominal value of 0,10 lei, repurchased according to Decision of the Extraordinary General Meeting of Shareholders of Farmaceutica REMEDIA S.A. no. 75 / 14.10.2020.
The new share capital of Farmaceutica REMEDIA S.A. will be 9.548.082 lei, divided into 95.480.820 shares, registered, dematerialized, with a nominal value of 0,10 lei.
Art. 2. Following the debate of the second point on the agenda, the Extraordinary General Meeting of the Shareholders decides, unanimously, by the votes of the shareholders present and represented:
Empowerment of the Board of Administrators for the adoption of all decisions necessary to carry out the Decision of the Extraordinary General Meeting of Shareholders to reduce the share capital.
Art. 3. Following the debate of the third point on the agenda, the Extraordinary General Meeting of the Shareholders decides, unanimously, by the votes of the shareholders present and represented:
Approval of the update of the Articles of Association of Farmaceutica REMEDIA SA, as follows:
Art. 6, para 6.1 will be modified and will have the following content:
”6.1. (1) The share capital of the Company is 9.548.082 lei, fully subscribed and paid.
(2) The share capital is divided into 95.480.820 registered, dematerialized shares, with a nominal value of 0,1 lei / 1 share.”
Art. 6, para 6.2 will be modified and will have the following content:
”6.2. The consolidated synthetic structure of the holders of financial instruments issued by Farmaceutica REMEDIA S.A., symbol RMAH, is according to the Register of holders of financial instruments kept by Depozitarul Central S.A.”.
Art. 4. Following the debate of the fourth point on the agenda, the Extraordinary General Meeting of the Shareholders decides, unanimously, by the votes of the shareholders present and represented:
Approval of the date of 16.03.2021 as the registration date, in compliance with the provisions of Art. 86 (1) of Law No. 24/2017.
Art. 5. Following the debate of the fifth point on the agenda, the Extraordinary General Meeting of the Shareholders decides, unanimously, by the votes of the shareholders present and represented:
Approval of the date of 15.03.2021 as ex-date, in compliance with the provisions of Art. 176 (1) from the FSA Regulation No. 5/2018 and Art. 2 (2) letter l from the FSA Regulation No. 5/2018.
Art. 6. Following the debate of the sixth point on the agenda, the Extraordinary General Meeting of the Shareholders decides, unanimously, by the votes of the shareholders present and represented:
The empowerment of “TARUS”– Valentin Norbert TARUS e.U., the President of the Board of Administrators, represented by Mr Valentin-Norbert TARUS, for signing all the documents issued following the Extraordinary General Meeting of Shareholders.
The President of the Extraordinary General Meeting of the Shareholders
Adrian-Marcel PARVU